Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Revenue: 2010-2024

Historic Revenue for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to $43.5 million.

  • CorMedix's Revenue rose 810.22% to $104.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.3 million, marking a year-over-year increase of 1775.48%. This contributed to the annual value of $43.5 million for FY2024, which is 126855.80% up from last year.
  • Latest data reveals that CorMedix reported Revenue of $43.5 million as of FY2024, which was up 126,855.80% from -$34,296 recorded in FY2023.
  • CorMedix's 5-year Revenue high stood at $43.5 million for FY2024, and its period low was -$34,296 during FY2023.
  • In the last 3 years, CorMedix's Revenue had a median value of $65,408 in 2022 and averaged $14.5 million.
  • As far as peak fluctuations go, CorMedix's Revenue crashed by 152.43% in 2023, and later soared by 126,855.80% in 2024.
  • Over the past 5 years, CorMedix's Revenue (Yearly) stood at $239,231 in 2020, then decreased by 20.19% to $190,936 in 2021, then plummeted by 65.74% to $65,408 in 2022, then tumbled by 152.43% to -$34,296 in 2023, then surged by 126,855.80% to $43.5 million in 2024.